Harpoon Therapeutics, Inc. Debt to Equity Ratio 2017-2023 | HARP
Current and historical debt to equity ratio values for Harpoon Therapeutics, Inc. (HARP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Harpoon Therapeutics, Inc. debt/equity for the three months ending September 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-09-30 | $0.04B | $0.01B | 9.48 |
| 2023-06-30 | $0.06B | $0.00B | 20.08 |
| 2023-03-31 | $0.08B | $0.00B | 112.02 |
| 2022-12-31 | $0.07B | $0.01B | 12.66 |
| 2022-09-30 | $0.07B | $0.02B | 3.94 |
| 2022-06-30 | $0.08B | $0.03B | 3.09 |
| 2022-03-31 | $0.09B | $0.04B | 2.20 |
| 2021-12-31 | $0.10B | $0.06B | 1.68 |
| 2021-09-30 | $0.10B | $0.08B | 1.27 |
| 2021-06-30 | $0.11B | $0.09B | 1.16 |
| 2021-03-31 | $0.16B | $0.10B | 1.55 |
| 2020-12-31 | $0.12B | $0.05B | 2.19 |
| 2020-09-30 | $0.12B | $0.06B | 2.02 |
| 2020-06-30 | $0.13B | $0.07B | 1.74 |
| 2020-03-31 | $0.08B | $0.08B | 0.95 |
| 2019-12-31 | $0.08B | $0.09B | 0.87 |
| 2019-09-30 | $0.04B | $0.11B | 0.33 |
| 2019-06-30 | $0.04B | $0.12B | 0.28 |
| 2019-03-31 | $0.00B | $0.00B | 0.00 |
| 2018-12-31 | $0.00B | 0.00 | |
| 2018-09-30 | $0.00B | $0.00B | 0.00 |
| 2018-06-30 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.06B | $-0.03B | -2.18 |
| 2016-12-31 | $0.00B | $0.00B | 0.00 |
